EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMDGlobeNewsWire • 10/19/26
These beaten-down stocks could bounce back in January, if history is any guideMarket Watch • 09/21/26
EyePoint, Inc. (EYPT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/15/26
EYPT Investigation Alert: EyePoint, Inc. Investors Encouraged to Contact Kessler Topaz Meltzer & Check, LLPGlobeNewsWire • 09/10/26
EyePoint, Inc. (EYPT) Presents at Citigroup's Biopharma Back to School Summit 2026 TranscriptSeeking Alpha • 09/09/26
Investigation Alert: EyePoint, Inc. (EYPT) Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLPPRNewsWire • 09/06/26
EyePoint, Inc. (NASDAQ: EYPT) Alert: Investors Encouraged to Contact KTMC Law FirmGlobeNewsWire • 09/04/26
EYPT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving EyePoint PharmaceuticalsGlobeNewsWire • 09/03/26
EYEPOINT STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating EyePoint, Inc. on Behalf of EyePoint Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 09/02/26
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific MeetingGlobeNewsWire • 09/02/26
EYPT SHAREHOLDER ALERT: EyePoint Pharmaceuticals Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws ViolationsBusiness Wire • 09/02/26
EYPT ALERT: Investigation Launched into EyePoint, Inc., Investors are Encouraged to Contact KTMC Law FirmPRNewsWire • 08/28/26
EYPT Investors Have Opportunity to Join EyePoint, Inc. Fraud Investigation with SBS LawBusiness Wire • 08/28/26
Kessler Topaz Meltzer & Check, LLP Encourages EyePoint, Inc. (NASDAQ: EYPT) Investors to Contact the FirmGlobeNewsWire • 08/27/26
EYEPOINT PHARMACEUTICALS INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities FraudGlobeNewsWire • 08/27/26
NASDAQ: EYPT Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages EyePoint, Inc. (NASDAQ: EYPT) Investors to Contact the FirmBusiness Wire • 08/26/26
EYPT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into EyePoint Pharmaceuticals (EYPT)Business Wire • 08/21/26
EyePoint: Sell-Off As Duravyu Fails Head-To-Head Study Vs Eylea May Be OverblownSeeking Alpha • 08/19/26
EYPT Stock Plunges 67% After Duravyu Misses Phase III Eye Disease GoalZacks Investment Research • 08/18/26
EyePoint, Inc. (EYPT) Discusses LUGANO Top Line Data From Phase III Wet AMD Trial for DURAVYU TranscriptSeeking Alpha • 08/18/26